CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials
Oxford BioMedica (United Kingdom) · University of Toronto · +52 more institutions
Abstract
This is comment on: Hopewell S, et al. CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials. BMJ. 2025 Apr 14;389:e081124. https://pubmed.ncbi.nlm.nih.gov/40228832 The CONSORT (2025) statement [1] writes about blinding as follows: “Unblinded outcome assessors may differentially assess subjective outcomes, and unblinded data analysts may introduce bias through the choice of analytical strategies, such as the selection of favourable time points or outcomes and by decisions to remove patients from the analyses. These biases have been well documented,” p.27 in [1]. One of the references to this statement, ref. no. 328, is to the trial by Karlowski, Chalmers et al. (1975) [2].…
Citation impact
- FWCI
- 410.99
- Percentile
- 100%
- References
- 500
Authors
39- SHSally HopewellCorresponding
Oxford BioMedica (United Kingdom)
- ACAn‐Wen Chan
University of Toronto, Women's College Hospital
- GSGary S. Collins
University of Oxford
- AHAsbjørn Hróbjartsson
University of Southern Denmark, Odense University Hospital, Cochrane
- DMDavid Moher
Ottawa Hospital, Ottawa Hospital Research Institute
Topics & keywords
- Elaboration
- Consolidated Standards of Reporting Trials
- Guideline
- Computer science
- Medicine
- Alternative medicine
- Pathology